MedTrace Logo

Impact of Vaccination on Th2 Immunity in Infancy

NCT02213341 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2019-07-23

No results posted yet for this study

Summary

The purpose of this study is to assess the responses in the immune system of infants after they receive the vaccine against diphtheria, tetanus, and pertussis (DTaP). The investigators will do this by studying the immune cells and allergy responses in the blood prior to and after receipt of the third DTaP vaccine.

Conditions

  • Food Hypersensitivity

Interventions

PROCEDURE

Skin prick allergen test

To test for hypersensitivity to milk, egg, or peanut

PROCEDURE

Blood draw

Sponsors & Collaborators

  • Consortium of Food Allergy Research

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Hugh A. Sampson, MD · Icahn School of Medicine at Mt. Sinai

  • Scott Sicherer, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
5 Months
Max Age
7 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2016-06-14
Completion
2016-06-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02213341 on ClinicalTrials.gov